Dose‐Dependent Carbon‐Dot‐Induced ROS Promote Uveal Melanoma Cell Tumorigenicity via Activation of mTOR Signaling and Glutamine Metabolism. Issue 8 (25th February 2021)
- Record Type:
- Journal Article
- Title:
- Dose‐Dependent Carbon‐Dot‐Induced ROS Promote Uveal Melanoma Cell Tumorigenicity via Activation of mTOR Signaling and Glutamine Metabolism. Issue 8 (25th February 2021)
- Main Title:
- Dose‐Dependent Carbon‐Dot‐Induced ROS Promote Uveal Melanoma Cell Tumorigenicity via Activation of mTOR Signaling and Glutamine Metabolism
- Authors:
- Ding, Yi
Yu, Jie
Chen, Xingyu
Wang, Shaoyun
Tu, Zhaoxu
Shen, Guangxia
Wang, Huixue
Jia, Renbing
Ge, Shengfang
Ruan, Jing
Leong, Kam W.
Fan, Xianqun - Abstract:
- Abstract: Uveal melanoma (UM) is the most common intraocular malignant tumor in adults and has a low survival rate following metastasis; it is derived from melanocytes susceptible to reactive oxygen species (ROS). Carbon dot (Cdot) nanoparticles are a promising tool in cancer detection and therapy due to their unique photophysical properties, low cytotoxicity, and efficient ROS productivity. However, the effects of Cdots on tumor metabolism and growth are not well characterized. Here, the effects of Cdots on UM cell metabolomics, growth, invasiveness, and tumorigenicity are investigated in vitro and in vivo zebrafish and nude mouse xenograft model. Cdots dose‐dependently increase ROS levels in UM cells. At Cdots concentrations below 100 µg mL −1, Cdot‐induced ROS promote UM cell growth, invasiveness, and tumorigenicity; at 200 µg mL −1, UM cells undergo apoptosis. The addition of antioxidants reverses the protumorigenic effects of Cdots. Cdots at 25–100 µg mL −1 activate Akt/mammalian target of rapamycin (mTOR) signaling and enhance glutamine metabolism, generating a cascade that promotes UM cell growth. These results demonstrate that moderate, subapoptotic doses of Cdots can promote UM cell tumorigenicity. This study lays the foundation for the rational application of ROS‐producing nanoparticles in tumor imaging and therapy. Abstract : Uveal melanoma (UM) originates from melanocytes that are susceptible to malignant transformation by reactive oxygen species (ROS). CarbonAbstract: Uveal melanoma (UM) is the most common intraocular malignant tumor in adults and has a low survival rate following metastasis; it is derived from melanocytes susceptible to reactive oxygen species (ROS). Carbon dot (Cdot) nanoparticles are a promising tool in cancer detection and therapy due to their unique photophysical properties, low cytotoxicity, and efficient ROS productivity. However, the effects of Cdots on tumor metabolism and growth are not well characterized. Here, the effects of Cdots on UM cell metabolomics, growth, invasiveness, and tumorigenicity are investigated in vitro and in vivo zebrafish and nude mouse xenograft model. Cdots dose‐dependently increase ROS levels in UM cells. At Cdots concentrations below 100 µg mL −1, Cdot‐induced ROS promote UM cell growth, invasiveness, and tumorigenicity; at 200 µg mL −1, UM cells undergo apoptosis. The addition of antioxidants reverses the protumorigenic effects of Cdots. Cdots at 25–100 µg mL −1 activate Akt/mammalian target of rapamycin (mTOR) signaling and enhance glutamine metabolism, generating a cascade that promotes UM cell growth. These results demonstrate that moderate, subapoptotic doses of Cdots can promote UM cell tumorigenicity. This study lays the foundation for the rational application of ROS‐producing nanoparticles in tumor imaging and therapy. Abstract : Uveal melanoma (UM) originates from melanocytes that are susceptible to malignant transformation by reactive oxygen species (ROS). Carbon dots (Cdots) with efficient ROS productivity dose‐dependently promote UM cell growth, invasiveness, and tumorigenicity at concentrations below 100 µg mL −1 . Cdot‐induced ROS act as stimulatory signaling molecules to activate Akt/mammalian target of rapamycin signaling, accelerate glutamine metabolism, thus promoting UM cell growth. … (more)
- Is Part Of:
- Advanced science. Volume 8:Issue 8(2021)
- Journal:
- Advanced science
- Issue:
- Volume 8:Issue 8(2021)
- Issue Display:
- Volume 8, Issue 8 (2021)
- Year:
- 2021
- Volume:
- 8
- Issue:
- 8
- Issue Sort Value:
- 2021-0008-0008-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2021-02-25
- Subjects:
- glutamine -- metabolomics -- mTOR -- ROS -- uveal melanoma
Science -- Periodicals
505 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2198-3844 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/advs.202002404 ↗
- Languages:
- English
- ISSNs:
- 2198-3844
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16558.xml